{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:12:13Z","timestamp":1747887133816,"version":"3.41.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["COBRE, P20 GM130414"],"award-info":[{"award-number":["COBRE, P20 GM130414"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-99130-5","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:44:08Z","timestamp":1747831448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opioid quantification via microsampling techniques to assess opioid use in human laboratory studies"],"prefix":"10.1038","volume":"15","author":[{"given":"Ramisa","family":"Fariha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Rothkopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina L.","family":"Haass-Koffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anubhav","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"99130_CR1","unstructured":"Opioid Use in the U.S. - Statistics & Facts. Accessed March 8, 2024. Available from: https:\/\/www.statista.com\/topics\/3197\/opioid-use-in-the-us\/#editorsPicks"},{"key":"99130_CR2","unstructured":"National Institutes of Health HEAL Initiative. Available from: https:\/\/heal.nih.gov\/"},{"issue":"2","key":"99130_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1369-1600.2008.00138.x","volume":"14","author":"M Sofuoglu","year":"2009","unstructured":"Sofuoglu, M. & Sewell, R. A. Norepinephrine and stimulant addiction. Addict. Biol. 14(2), 119\u2013129. https:\/\/doi.org\/10.1111\/j.1369-1600.2008.00138.x (2009).","journal-title":"Addict. Biol."},{"issue":"2","key":"99130_CR4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40263-016-0313-z","volume":"30","author":"MR Lee","year":"2016","unstructured":"Lee, M. R., Rohn, M. C. H., Tanda, G. & Leggio, L. Targeting the oxytocin system to treat addictive disorders: Rationale and progress to date. CNS Drugs 30(2), 109\u2013123. https:\/\/doi.org\/10.1007\/s40263-016-0313-z (2016).","journal-title":"CNS Drugs"},{"issue":"14","key":"99130_CR5","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1097\/00001756-200009280-00015","volume":"11","author":"ZD You","year":"2000","unstructured":"You, Z. D., Li, J. H., Song, C. Y., Wang, C. H. & Lu, C. L. Chronic morphine treatment inhibits oxytocin synthesis in rats. NeuroReport 11(14), 3113\u20133116. https:\/\/doi.org\/10.1097\/00001756-200009280-00015 (2000).","journal-title":"NeuroReport"},{"issue":"44","key":"99130_CR6","doi-asserted-by":"publisher","first-page":"14503","DOI":"10.1523\/JNEUROSCI.3509-14.2014","volume":"34","author":"DS Carson","year":"2014","unstructured":"Carson, D. S. Oxytocin treatment for amphetamine-induced social impairments. J. Neurosci. 34(44), 14503\u201314505. https:\/\/doi.org\/10.1523\/JNEUROSCI.3509-14.2014 (2014).","journal-title":"J. Neurosci."},{"key":"99130_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pbb.2013.11.019","volume":"119","author":"Z Sarnyai","year":"2014","unstructured":"Sarnyai, Z. & Kov\u00e1cs, G. L. Oxytocin in learning and addiction: From early discoveries to the present. Pharmacol. Biochem. Behav. 119, 3\u20139. https:\/\/doi.org\/10.1016\/j.pbb.2013.11.019 (2014).","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"99130_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","volume":"1","author":"T Kosten","year":"2002","unstructured":"Kosten, T. & George, T. The neurobiology of opioid dependence: Implications for treatment. SPP 1(1), 13\u201320. https:\/\/doi.org\/10.1151\/spp021113 (2002).","journal-title":"SPP"},{"key":"99130_CR9","doi-asserted-by":"publisher","first-page":"146761","DOI":"10.1016\/j.brainres.2020.146761","volume":"1736","author":"CE King","year":"2020","unstructured":"King, C. E., Gano, A. & Becker, H. C. The role of oxytocin in alcohol and drug abuse. Brain Res. 1736, 146761. https:\/\/doi.org\/10.1016\/j.brainres.2020.146761 (2020).","journal-title":"Brain Res."},{"key":"99130_CR10","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.12f01371","author":"CJ Keary","year":"2012","unstructured":"Keary, C. J. et al. Toxicologic testing for opiates: Understanding false-positive and false-negative test results. Prim. Care Compan. CNS Disord. https:\/\/doi.org\/10.4088\/PCC.12f01371 (2012).","journal-title":"Prim. Care Compan. CNS Disord."},{"issue":"4","key":"99130_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1524-475X.2009.00513.x","volume":"17","author":"B Pieper","year":"2009","unstructured":"Pieper, B., Templin, T. N., Kirsner, R. S. & Birk, T. J. Impact of injection drug use on distribution and severity of chronic venous disorders. Wound Repair Regen. 17(4), 485\u2013491. https:\/\/doi.org\/10.1111\/j.1524-475X.2009.00513.x (2009).","journal-title":"Wound Repair Regen."},{"key":"99130_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2015.08.016","volume":"57","author":"P Kamilar-Britt","year":"2015","unstructured":"Kamilar-Britt, P. & Bedi, G. The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. Neurosci. Biobehav. Rev. 57, 433\u2013446. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.08.016 (2015).","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"99130_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/21507740.2013.796328","volume":"4","author":"R Hammer","year":"2013","unstructured":"Hammer, R. et al. Addiction: Current criticism of the brain disease paradigm. AJOB Neurosci. 4(3), 27\u201332. https:\/\/doi.org\/10.1080\/21507740.2013.796328 (2013).","journal-title":"AJOB Neurosci."},{"issue":"3","key":"99130_CR14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke, S. Self-report among injecting drug users: A review. Drug Alcohol Depend. 51(3), 253\u2013263. https:\/\/doi.org\/10.1016\/S0376-8716(98)00028-3 (1998).","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"99130_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1360-0443.1998.9345157.x","volume":"93","author":"LA Marsch","year":"1998","unstructured":"Marsch, L. A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 93(4), 515\u2013532. https:\/\/doi.org\/10.1046\/j.1360-0443.1998.9345157.x (1998).","journal-title":"Addiction"},{"issue":"5","key":"99130_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jat\/33.5.243","volume":"33","author":"A De Castro","year":"2009","unstructured":"De Castro, A. et al. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. J. Anal Toxicol. 33(5), 243\u2013252. https:\/\/doi.org\/10.1093\/jat\/33.5.243 (2009).","journal-title":"J. Anal Toxicol."},{"issue":"1","key":"99130_CR17","doi-asserted-by":"publisher","first-page":"11569","DOI":"10.1038\/s41598-020-68348-w","volume":"10","author":"N Qin","year":"2020","unstructured":"Qin, N. et al. Determination of 37 fentanyl analogues and novel synthetic opioids in hair by UHPLC-MS\/MS and its application to authentic cases. Sci. Rep. 10(1), 11569. https:\/\/doi.org\/10.1038\/s41598-020-68348-w (2020).","journal-title":"Sci. Rep."},{"issue":"5","key":"99130_CR18","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1021\/acs.jproteome.9b00867","volume":"19","author":"JL Nickerson","year":"2020","unstructured":"Nickerson, J. L. & Doucette, A. A. Rapid and quantitative protein precipitation for proteome analysis by mass spectrometry. J. Proteome Res. 19(5), 2035\u20132042. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00867 (2020).","journal-title":"J. Proteome Res."},{"key":"99130_CR19","doi-asserted-by":"publisher","DOI":"10.3791\/51670","author":"C Cruickshank-Quinn","year":"2014","unstructured":"Cruickshank-Quinn, C. et al. Multi-step preparation technique to recover multiple metabolite compound classes for in-depth and informative metabolomic analysis. JoVE https:\/\/doi.org\/10.3791\/51670 (2014).","journal-title":"JoVE"},{"key":"99130_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s13181-012-0274-7","volume":"8","author":"MC Milone","year":"2012","unstructured":"Milone, M. C. Laboratory testing for prescription opioids. J. Med. Toxicol. 8, 408\u2013416. https:\/\/doi.org\/10.1007\/s13181-012-0274-7 (2012).","journal-title":"J. Med. Toxicol."},{"key":"99130_CR21","doi-asserted-by":"publisher","first-page":"100395","DOI":"10.1016\/j.bpsgos.2024.100395","volume":"5","author":"BJ Gully","year":"2025","unstructured":"Gully, B. J. et al. Oxytocin reduces noradrenergic-induced opioid-like withdrawal symptoms in individuals on opioid agonist therapy. Biol. Psychiatry Global Open Sci. 5, 100395. https:\/\/doi.org\/10.1016\/j.bpsgos.2024.100395 (2025).","journal-title":"Biol. Psychiatry Global Open Sci."},{"key":"99130_CR22","doi-asserted-by":"publisher","first-page":"123438","DOI":"10.1016\/j.jchromb.2022.123438","volume":"1210","author":"HC Liao","year":"2022","unstructured":"Liao, H. C., Laha, T. J., Baird, G. S., Chan, K. K. & Hoofnagle, A. N. A Second-generation opioid LC-MS\/MS assay improves laboratory workflow and capacity. J. Chromatogr. B 1210, 123438. https:\/\/doi.org\/10.1016\/j.jchromb.2022.123438 (2022).","journal-title":"J. Chromatogr. B"},{"key":"99130_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.chroma.2016.03.076","volume":"1446","author":"MJ Swortwood","year":"2016","unstructured":"Swortwood, M. J., Scheidweiler, K. B., Barnes, A. J., Jansson, L. M. & Huestis, M. A. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography\u2013tandem mass spectrometry. J. Chromatogr. A 1446, 70\u201377. https:\/\/doi.org\/10.1016\/j.chroma.2016.03.076 (2016).","journal-title":"J. Chromatogr. A"},{"key":"99130_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cca.2014.06.023","volume":"437","author":"PC Mathias","year":"2014","unstructured":"Mathias, P. C., Hayden, J. A., Laha, T. J. & Hoofnagle, A. N. Evaluation of matrix effects using a spike recovery approach in a dilute-and-inject liquid chromatography\u2013tandem mass spectrometry opioid monitoring assay. Clin. Chim. Acta 437, 38\u201342. https:\/\/doi.org\/10.1016\/j.cca.2014.06.023 (2014).","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"99130_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13273-011-0025-x","volume":"7","author":"KY Kim","year":"2011","unstructured":"Kim, K. Y., Kang, J. H., Kim, C. W. & Nam, M. Application of liquid chromatography tandem mass spectrometry for the simultaneous quantification of multiple non-opioid drugs in human plasma. Mol. Cell. Toxicol. 7(2), 185\u2013189. https:\/\/doi.org\/10.1007\/s13273-011-0025-x (2011).","journal-title":"Mol. Cell. Toxicol."},{"issue":"5","key":"99130_CR26","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00216-008-2326-z","volume":"392","author":"SL Kacinko","year":"2008","unstructured":"Kacinko, S. L., Concheiro-Guisan, M., Shakleya, D. M. & Huestis, M. A. Development and validation of a liquid chromatography\u2013tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine. Anal. Bioanal. Chem. 392(5), 903\u2013911. https:\/\/doi.org\/10.1007\/s00216-008-2326-z (2008).","journal-title":"Anal. Bioanal. Chem."},{"key":"99130_CR27","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1038\/s41598-023-29229-0","volume":"13","author":"R Fariha","year":"2023","unstructured":"Fariha, R. et al. An in-depth analysis of four classes of antidepressants quantification from human serum using LC-MS\/MS. Sci. Rep. 13, 2115. https:\/\/doi.org\/10.1038\/s41598-023-29229-0 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"99130_CR28","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1023\/A:1015994030251","volume":"05","author":"SD Roy","year":"1988","unstructured":"Roy, S. D. & Flynn, G. L. Solubility behavior of narcotis analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil. Pharm. Res. 05(9), 580\u2013586. https:\/\/doi.org\/10.1023\/A:1015994030251 (1988).","journal-title":"Pharm. Res."},{"issue":"2","key":"99130_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/15360288.2011.573527","volume":"25","author":"OA Linares","year":"2011","unstructured":"Linares, O. A. & Linares, A. L. Computational opioid prescribing: A novel application of clinical pharmacokinetics. J. Pain Palliat. Care Pharmacother. 25(2), 125\u2013135. https:\/\/doi.org\/10.3109\/15360288.2011.573527 (2011).","journal-title":"J. Pain Palliat. Care Pharmacother."},{"issue":"16","key":"99130_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.15585\/mmwr.mm6516e1","volume":"65","author":"KT Vo","year":"2016","unstructured":"Vo, K. T., van Wijk, X. M., Lynch, K. L., Wu, A. H. & Smollin, C. G. Counterfeit norco poisoning outbreak\u2014San Francisco bay area, California, March 25\u2013April 5, 2016. MMWR Morb. Mortal Wkly. Rep. 65(16), 420\u2013423. https:\/\/doi.org\/10.15585\/mmwr.mm6516e1 (2016).","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"99130_CR31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.slast.2022.01.006","volume":"27","author":"R Fariha","year":"2022","unstructured":"Fariha, R. et al. Simultaneous detection of salivary cortisol and cortisone using an automated high-throughput sample preparation method for LC-MS\/MS. SLAS Technol. 27, 237\u2013246. https:\/\/doi.org\/10.1016\/j.slast.2022.01.006 (2022).","journal-title":"SLAS Technol."},{"issue":"4","key":"99130_CR32","first-page":"457","volume":"56","author":"JM DenHerder","year":"2017","unstructured":"DenHerder, J. M. et al. Effects of time and storage conditions on the chemical and microbiologic stability of diluted buprenorphine for injection. J. Am. Assoc. Lab. Anim. Sci. 56(4), 457\u2013461 (2017).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"issue":"19","key":"99130_CR33","doi-asserted-by":"publisher","first-page":"6761","DOI":"10.3390\/molecules27196761","volume":"27","author":"S Yasien","year":"2022","unstructured":"Yasien, S. et al. Simultaneous quantification of opioids in blood and urine by gas chromatography-mass spectrometer with modified dispersive solid-phase extraction technique. Molecules 27(19), 6761. https:\/\/doi.org\/10.3390\/molecules27196761 (2022).","journal-title":"Molecules"},{"key":"99130_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jpba.2019.01.014","volume":"166","author":"M Agostini","year":"2019","unstructured":"Agostini, M. et al. Rapid, hydrolysis-free, dilute-and-shoot method for the determination of buprenorphine, norbuprenorphine and their glucuronides in urine samples using UHPLC-MS\/MS. J. Pharm. Biomed. Anal. 166, 236\u2013243. https:\/\/doi.org\/10.1016\/j.jpba.2019.01.014 (2019).","journal-title":"J. Pharm. Biomed. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99130-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99130-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99130-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:44:10Z","timestamp":1747831450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-99130-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["99130"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-99130-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17678"}}